Original Research [OR]
1. Shah NB, Nigwekar SU, Kalim S, Lelouvier B, Servant F, Dalal M, Krinsky S, Fasano A, Tolkoff-Rubin N, & Allegretti AS, et al.. The Gut and Blood Microbiome in IgA Nephropathy and Healthy Controls. Kidney360. 2021;2(8):1261-1274.
2. Shah NB, Allegretti AS, Nigwekar SU, Kalim S, Zhao S, Lelouvier B, Servant F, Serena G, Thadhani RI, Raj DS, Fasano A. Blood Microbiome Profile in CKD: A Pilot Study. Clin J Am Soc Nephrol. 2019;14(5):692-701
3. Panesar M, Shah N, Vaqar S, Ivaturi K, Gudleski G, Muscarella M, Lambert J, Su W, Murray B. Ther Apher Dial. 2017;21(2):157-165.
Review Articles [RA]
1. ShahN, Rabb H. Intestinal Microbiota in Experimental Acute Kidney Injury. Nephron. 2022 Oct 4; 1-6.
Case Reports[CR]
1. Shah N, Rosales I, Smith RN, Berchuck JE, Yee AJ, Tolkoff-Rubin N. When acute kidney injury in the intensive care unit is not acute tubular necrosis: A case report of κ-light chain crystalline tubulopathy. Clin Nephrol. 2019;91(5):311-316.
2. Parris TC and Shah NB. What Are the Signs and Symptoms of Kidney Disease? In Williams WW (Ed). Facing Chronic Kidney Disease – A guide for Patients and Their Families. MGH Psychiatry Academy. Boston, 2022; 17-24.
Book Chapters [BC]
1. Regunathan-Shenk R, Shah NB, & Raj DS. The gut microbiome and the kidney. Nutritional Management of Renal Disease, 2022; 147–161.
2. Parris TC and Shah NB. What Are the Signs and Symptoms of Kidney Disease? In Williams WW (Ed). Facing Chronic Kidney Disease – A guide for Patients and Their Families. MGH Psychiatry Academy. Boston, 2022; 17-24.
Brief Reports:
1. Shah N, Rennke H, Czarnecki P, Domecq Garces JP, Ding Y, Mount D. “Methylphenidate Associated Antiphospholipid Antibody Syndrome Mediated AKI”. American Society of Nephrology 2017 abstract supplement (#2786167).
2. Inker L, Tighiouart H, Shah N, Appel G, Maes B, Li P, Praga M, Greene T, Schmid C, Levey A. “Reduction in Urine Protein as a Surrogate Marker for Kidney Disease Outcomes in IgA Nephropathy” J Am Soc Nephrol. 2012, Nov; 23(TH-PO423): 195A
